Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Autologous Endometrial Coculture (AECCT) (AECCT)

This study has been terminated.
(poor recruitment)
Information provided by (Responsible Party):
Weill Medical College of Cornell University Identifier:
First received: November 11, 2011
Last updated: June 10, 2015
Last verified: June 2015
The purpose of this study is to determine if the use of Autologous Endometrial Coculture (AECC) in young in vitro fertilization (IVF) patients with poor ovarian reserve improves pregnancy outcome.

Condition Intervention
Procedure: AECC (Autologous endometrial coculture)
Other: no endometrial biopsy or Autologous endometrial coculture (AECC) performed

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial Evaluating Autologous Endometrial Coculture (AECC) As An Effective Tool For Young Patients With Poor Ovarian Reserve

Resource links provided by NLM:

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • Pregnancy outcome [ Time Frame: 1 month ]

Secondary Outcome Measures:
  • Embryo quality [ Time Frame: 1 month ]

Enrollment: 20
Study Start Date: October 2009
Study Completion Date: June 2015
Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: No AECC
Routine procedures without AECC
Other: no endometrial biopsy or Autologous endometrial coculture (AECC) performed
routine procedures with out biopsy
Experimental: AECC
Endometrial biopsy and Autologous endometrial coculture
Procedure: AECC (Autologous endometrial coculture)
endometrial biopsy with autologous endometrial coculture

Detailed Description:
Young women with poor ovarian reserve are commonly given a poor prognosis for IVF success. Standard culture media for fertilizing oocytes (unfertilized eggs) is commonly used in IVF which closely resembles tubal fluid. Efforts to create optimal culture conditions for fertilization of human embryos for women with poor quality embryos and/or repeated implantation failures have been developed at our center by using AECC. AECC involves placing a patient's fertilized eggs on top of a layer of cells from her own uterine lining, creating a more natural environment for embryo development and maximizing the chance for IVF pregnancy. The investigators will prospectively randomize young patients (≤ age 38 years) poor ovarian reserve to AECC or no AECC with standard culture media to study pregnancy outcome.

Ages Eligible for Study:   18 Years to 38 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy women undergoing IVF at CRMI
  • Age ≤ 38 years
  • Poor ovarian reserve with antral follicle count less than 6 follicles, cycle day 2/3 FSH > 12 ng/ml, AMH < 0.5 ng/ml

Exclusion Criteria:

  • Healthy women undergoing IVF with male factor, severe endometriosis, or tubal factor infertility
  • Donor patients
  • Contraindications for the use of gonadotropins (i.e. pregnancy, lactation, undiagnosed vaginal bleeding or ovarian cysts)
  • Recent or current medical conditions where the patient is not medically stable to undergo stimulation or egg retrieval, HIV infection, diabetes, cardiovascular disease, gastrointestinal, hepatic disease, renal or pulmonary disease.
  • Any patient who is not a candidate for IVF
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01472861

United States, New York
Center for Reproducutve Medicine; Weill Cornell Medical College
New York, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
Principal Investigator: Spandorfer Steven, MD Weill Medical College
  More Information

Additional Information:
Responsible Party: Weill Medical College of Cornell University Identifier: NCT01472861     History of Changes
Other Study ID Numbers: 0903010293
Study First Received: November 11, 2011
Last Updated: June 10, 2015

Keywords provided by Weill Medical College of Cornell University:
endometrial biopsy
IVF poor responders

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female processed this record on May 25, 2017